Spagnoli Family Cancer Center
Orange Regional Medical Center
707 East Main Street
Middletown, NY 10940
Orange Regional Medical Center has an active Clinical Oncology Trials program in place. Through our affiliation with Columbia University Medical Center, Orange Regional Medical Center participates in the Southwest Oncology Group Studies. We also participate in American College of Surgeons Oncology Group (ACOSOG) studies, Radiation Therapy Oncology Group (RTOG) and other Inter-group studies through the Cancer Trials Support Unit (CTSU) of the National Cancer Institute.
Clinical trials provide patients at all stages of cancer with leading edge medical treatment and the highest level of care. In most cases, the new treatment has already shown promise of being an improvement over the standard treatment. Many clinical trials are tests to see how much better a new treatment works than the current one.
Frequently Asked Questions
As of July 8, 2013, Orange Regional Medical Center has 33 open phase II or III clinical trials, which were approved for patient enrollment by our Institutional Review Board (IRB). Disease sites include:
Under FDA regulations, an IRB is an appropriately constituted group that has been formally designated to review and monitor biomedical research involving human subjects. The IRB reviews and has authority to approve, require modifications in (to secure approval), or disapprove all research activities. This group review serves an important role in
the protection of the rights and welfare of human research subjects. All protocols must be approved by the IRB prior to enrolling any study patients. Orange Regional Medical Center's IRB is made up of an equal amount of hospital employees and community members.
Anyone interested in learning more about our clinical trials or the IRB may contact our research coordinator: Jessica Gerlach, CCRP (Certified Clinical Research Professional) at 845-333-1133 or email@example.com.
To read more about our Clinical Trials and additional Oncology Services, please view our 2011 Oncology Annual Report.
For more information on clinical trials, please visit